Neuroscience: News from our Laboratories

Research highlight

Progress Against Brain Cancer

Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.

Patrick Griffin, Ph.D.; Courtney Miller, Ph.D., and Theodore Kamenecka, Ph.D., discuss their work as they walk through Miller's lab at The Wertheim UF Scripps Institute.

Movie Night Features Documentary On Biotech…

“Cracking the Code,” a documentary narrated by Mark Ruffalo, is an inspiring story of vision, perseverance, and the power of science to change the…

Graphic shows still of Phil Sharp in the lab. Announces screening of documentary, "Cracking the Code" on Nov. 14, 2025, at The Wertheim UF Scripps Institute.

Wertheim UF Scripps Institute Research Garners…

“These grants highlight The Wertheim UF Scripps Institute’s unique expertise in areas that include neuroscience, immunology, biochemistry, drug…

HIV infected T cell, courtesy of NIH.

Scientists Wipe Out Aggressive Brain Cancer…

Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF…

Patrick Griffin, Ph.D.; Courtney Miller, Ph.D., and Theodore Kamenecka, Ph.D., discuss their work as they walk through Miller's lab at The Wertheim UF Scripps Institute.